Market Cap: $34.76B
Market Cap: $34.76B
Open
$75.48
Prev. Close
$83.48
High
$75.48
Low
$73.06
Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools.
Zoetis Inc. trades on the New York Stock Exchange under the ticker ZTS, priced in USD.
Zoetis Inc. has a market capitalisation of $34.76B, based on its latest share price.
ZTS trades at 14.20 times its trailing 12-month earnings.
Over the past 52 weeks ZTS has traded between $68.77 and $132.49.
Yes. Zoetis Inc.'s dividend yields 2.54% at the current share price, paying out 36% of its earnings.
Highly profitable: keeps 26.1% of revenue as net profit.
Kristin C. Peck is the CEO of Zoetis Inc., which is headquartered in Parsippany.
Generated automatically from reported financial data. General information only, not financial advice.

Zoetis Inc. ( ZTS ) is currently navigating a complex landscape marked by regulatory challenges, declining product demand , and legal complications that threaten its operational and financial stabilit…

Zoetis Inc. ( ZTS ) is currently confronting a myriad of challenges that jeopardize its operational stability and financial performance. As a leader in the animal health sector, Zoetis has enjoyed a s…

Zoetis Inc. ( ZTS ) is currently navigating a set of challenges that have emerged as acute concerns for the company and its investors. As a leading player in the animal health sector, the firm has est…

Zoetis Inc. ( ZTS ) is currently grappling with multiple headwinds that have significant implications for its operational and financial health. As a leading player in the animal health industry, Zoeti…